Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polypeptide reagent for activating human immune cells

A technology of immune cells and peptide reagents, applied in the field of tumor immunology, can solve problems such as inability to obtain results

Inactive Publication Date: 2020-05-12
定山石生物科技(北京)有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] According to the above-mentioned analysis of the difference between humoral immunity and cellular immunity, in the past, the medical field searched for tumor-specific antigens and completely followed the methods and standards of microbial antigens, and may not be able to obtain the desired results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptide reagent for activating human immune cells
  • Polypeptide reagent for activating human immune cells
  • Polypeptide reagent for activating human immune cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] In the following description, numerous specific details are set forth in order to provide a more thorough understanding of the present invention. It will be apparent, however, to one skilled in the art that embodiments of the invention may be practiced without one or more of these details. In other instances, some technical features known in the art are not described in order to avoid confusion with the embodiments of the present invention.

[0022] For a thorough understanding of the embodiments of the present invention, detailed structures will be presented in the following description. Obviously, the implementation of the embodiments of the present invention is not limited to the specific details familiar to those skilled in the art. The preferred embodiments of the present invention are described in detail below, however, the present invention may have other embodiments in addition to these detailed descriptions.

[0023] In the description of the present inventio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Cell concentrationaaaaaaaaaa
Login to View More

Abstract

The invention provides a polypeptide reagent for activating human immune cells. The polypeptide reagent comprises 6-aminopurine, folic acid, glycyl-L-glutamine, L-glutathione, thymopentin, Pp25 and Pp21, wherein Pp25 and Pp21 are prepared by a solid-phase polypeptide synthesis technology.

Description

technical field [0001] The invention relates to the technical field of tumor immunology, in particular to a polypeptide reagent for activating human immune cells. Background technique [0002] Cancer is a major disease that threatens human life, and biological immunology is considered to be the only possible way to completely cure cancer. [0003] At present, the mainstream idea of ​​tumor immunology research is to search for tumor-specific antigens and try to sensitize immune cells with tumor-specific antigens, so as to rely on immune cells to kill tumor cells and achieve the purpose of curing cancer. ——This idea is similar to microbial vaccines and snake venom antiserum: both microbial vaccines and snake venom antiserum rely on the preparation of specific antigens to sensitize the immune system to obtain reliable disease resistance. In contrast, tumor-specific antigens are far from successful, and humans have not even been able to confirm whether tumor-specific antigens a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/17A61P35/00A61K31/519A61K31/52A61K38/05A61K38/06A61K38/08
CPCA61K31/519A61K38/06A61K31/52A61K38/08A61K38/05A61K38/17A61P37/04A61P35/00
Inventor 陈德钊
Owner 定山石生物科技(北京)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com